Utility and impact of quantitative pharmacology on dose selection and clinical development of immuno-oncology therapy Yan JiSherwin K. B. Sy Review Article 02 March 2024 Pages: 273 - 293
CUDC-907 exhibits potent antitumor effects against ovarian cancer through multiple in vivo and in vitro mechanisms Yuanpei WangJing WenFang Ren Original Article 08 November 2023 Pages: 295 - 306
Relative bioavailability of fedratinib through various alternative oral administration methods in healthy adults Yizhe ChenDavid WyattGopal Krishna Original Article Open access 13 November 2023 Pages: 307 - 317
Quantitative assessment of skin disorders induced by panitumumab: a prospective observational study Hiroaki TakahashiYoko SaitoKenzo Kudo Original Article 28 November 2023 Pages: 319 - 328
Pharmacokinetics and immunogenicity of eftozanermin alfa in subjects with previously-treated solid tumors or hematologic malignancies: results from a phase 1 first-in-human study Carla BiesdorfXiaowen GuanAkshanth R. Polepally Original Article 30 November 2023 Pages: 329 - 339
Safety and pharmacokinetics of imaradenant (AZD4635) in Japanese patients with advanced solid malignancies: a phase I, open-label study Nobuaki MatsubaraShota KusuharaToshio Shimizu Original Article Open access 13 December 2023 Pages: 341 - 352
Real-world data on the management of pazopanib-induced liver toxicity in routine care of renal cell cancer and soft tissue sarcoma patients K. WesterdijkS. D. KrensN. P. van Erp Original Article Open access 17 December 2023 Pages: 353 - 364
Translational PK-PD/TD modeling of antitumor effects and peripheral neuropathy in gemcitabine and nab-paclitaxel chemotherapy from xenograft mice to patients for optimal dose and schedule Shinji KobuchiAtsuko MoritaYukako Ito Original Article 20 December 2023 Pages: 365 - 379
Andrographolide inhibits Burkitt’s lymphoma by binding JUN and CASP3 proteins Junquan ZengYongliang ZhengTingting Liu Original Article Open access 26 December 2023 Pages: 381 - 391
Prospective validation of an equation based on plasma cystatin C for monitoring the glomerular filtration rate in children treated with cisplatin or ifosfamide for cancer Marie LambertMathieu AlonsoEtienne Chatelut Short Communication 03 October 2023 Pages: 393 - 395